Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	17738
Country	Belgium

Received	2015-03-22 10:28
Peer-Review Started	2015-03-22 12:34
To Make the First Decision	2015-06-25 17:55
Return for Revision	2015-07-01 10:48
Revised	2015-07-06 17:26
Second Decision	2015-07-21 19:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-08-03 15:29
Articles in Press	2015-08-03 15:29
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-06 15:48
Publish the Manuscript Online	2015-09-17 15:08

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Intrahepatic therapy for liver-dominant metastatic colorectal cancer
Manuscript Source	Invited Manuscript
All Author List	Kerlijne De Groote and Hans Prenen
Funding Agency and Grant Number
Corresponding Author	Hans Prenen, MD, Professor of medicine, Department of Gastroenterology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. hans.prenen@uzleuven.be
Key Words	Colorectal cancer; Liver metastases; Intra­hepatic treatment; Chemoembolization; Radioem­boli­sation
Core Tip	Thanks to the increased chemotherapeutic options in patients with metastatic colorectal cancer (mCRC), the overall survival has significantly improved the last decade. Liver failure is a common cause of death in mCRC with liver metastases. Therefore in these patients locoregional treatment is a valuable treatment option in order to increase survival. In this review we provide insights on the published literature.
Publish Date	2015-09-17 15:08
Citation	De Groote K, Prenen H. Intrahepatic therapy for liver-dominant metastatic colorectal cancer. World J Gastrointest Oncol 2015; 7(9): 148-152
URL	http://www.wjgnet.com/1948-5204/full/v7/i9/148.htm
DOI	http://dx.doi.org/10.4251/wjgo.v7.i9.148

Full Article (PDF)	WJGO-7-148.pdf
Full Article (Word)	WJGO-7-148.doc
Manuscript File	17738-Review.docx
Answering Reviewers	17738-Answering reviewers.pdf
Audio Core Tip	17738-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	17738-Conflict-of-interest statement.pdf
Copyright License Agreement	17738-Copyright assignment.pdf
Peer-review Report	17738-Peer-review(s).pdf
Scientific Misconduct Check	17738-Scientific misconduct check.pdf
Scientific Editor Work List	17738-Scientific editor work list.pdf